, Volume 29, Issue 12, pp 1015–1023

QALYs and Carers

Current Opinion QALYs and Carers

DOI: 10.2165/11593940-000000000-00000

Cite this article as:
Al-Janabi, H., Flynn, T.N. & Coast, J. Pharmacoeconomics (2011) 29: 1015. doi:10.2165/11593940-000000000-00000


When going ‘beyond the patient’, to measure QALYs for unpaid carers, a number of additional methodological considerations and value judgements must be made. While there is no theoretical reason to restrict the measurement of QALYs to patients, decisions have to be made about which carers to consider, what instruments to use and how to aggregate and present QALYs for carers and patients. Current, albeit limited, practice in measuring QALY gains to carers in economic evaluation varies, suggesting that there may be inconsistency in judgements about whether interventions are deemed cost effective.

While conventional health-related quality-of-life tools can, in theory, be used to estimate QALYs, there are both theoretical and empirical concerns over the suitability of their use with carers. Measures that take a broader view of health or well-being may be more appropriate. Incorporating QALYs of carers in economic evaluations may have important distributional consequences and, therefore, greater normative discussion over the appropriateness of incorporating these impacts is required. In the longer term, more flexible forms of cost-per-QALY analysis may be required to take account of the broader impacts on carers and the weight these impacts should receive in decision making.

Copyright information

© Springer International Publishing AG 2011

Authors and Affiliations

  • Hareth Al-Janabi
    • 1
  • Terry N. Flynn
    • 2
  • Joanna Coast
    • 1
  1. 1.Health Economics UnitUniversity of BirminghamBirminghamUK
  2. 2.Centre for the Study of Choice (CenSoC), University of Technology SydneySydneyAustralia

Personalised recommendations